. Author manuscript; available in PMC: 2011 Mar 1.

Published in final edited form as: J Assoc Nurses AIDS Care. 2009 Oct 4;21(2):162–172. doi: 10.1016/j.jana.2009.08.002

Table 2.

Relationship of AGAS to Adherence and Clinical Measures from GBL and KHARMA

	MEMS (% of prescribed doses taken)	MEMS (% of prescribed doses taken on schedule)	AACTG Reasons for Missing medications Scale	CESD	Viral Load Log	CD4 cell Count
GBL	29^** (n = 210)		−.50^** (n = 218)	−.26^** (n = 218)	−.16⁺ (n = 149)	.18^* (n = 136)
KHARMA	.24^** (n = 200)	.30^** (n = 200)	−.59^** (n = 206)	−.19^** (n = 206)	−.30^** (n = 169)	.18^* (n = 145)

Note. MEMS = Medication Event Monitoring System Cap; AACTG = Adults AIDS Clinical Trials Group Adherence Instruments; CESD = Center for Epidemiologic Studies Depression Scale.

Pearson correlation coefficients

p < .05

^**

p < .01

⁺

p < .1